Form D · Biotechnology

AQUESYS INC

Aliso Viejo, CA · CIK 0001406412

Offering snapshot reported Jan 21, 2014 · SEC filing

Reported sold
$30M
Offering amount: $30M
Investors reported
10
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 15, 2014
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 21, 2014Initial$30,000,000No comparison10SEC filing
May 9, 2012Initial$12,000,000No comparison8SEC filing
Jun 11, 2010Initial$7,500,000No comparison8SEC filing
Jul 15, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Jul 9, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-210399

Source: Form D, filed Jan 21, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Ron Bache Director, Executive
Julie Bakker Director
Juliet Tammenoms Bakker Director
Andrew Corley Director
Gregory Grunberg Director
Anthony Lando Director
David Milne Director
Edward Peterson Director
Ryan Schwarz Director
Michael Tyson Executive
Steven Waite Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
26970 Aliso Viejo Parkway Suite 200
Aliso Viejo, CA, 92656